Clinical Trial Update: Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing ibandronate to placebo to prevent bone loss after renal transplantation, spanning Phase 2 and Phase 3; status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Ibandronate (ibandronate)

Snippet

Sponsor: Smerud Medical Research International AS | Conditions: Renal Transplant | Phase 2, Phase 3 | Status: UNKNOWN